Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI studyResearch in context

Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI studyResearch in context

Summary: Background: European data pre-2019 suggest statin monotherapy is the most common approach to lipid management for preventing cardiovascular (CV) events, resulting in only one-fifth of high- and very high-risk patients achieving the 2019 ESC/EAS recommended low-density lipoprotein cholester...

Full description

Bibliographic Details
Main Authors: Kausik K. Ray, Inaam Haq, Aikaterini Bilitou, Marius C. Manu, Annie Burden, Carlos Aguiar, Marcello Arca, Derek L. Connolly, Mats Eriksson, Jean Ferrières, Ulrich Laufs, Jose M. Mostaza, David Nanchen, Ernst Rietzschel, Timo Strandberg, Hermann Toplak, Frank L.J. Visseren, Alberico L. Catapano
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:The Lancet Regional Health. Europe
Subjects:
Cardiovascular disease
LDL cholesterol
High cardiovascular risk
Lipid-lowering therapy
Real-world evidence
Cohort study
Online Access:http://www.sciencedirect.com/science/article/pii/S2666776223000431

Internet

http://www.sciencedirect.com/science/article/pii/S2666776223000431

Similar Items